Close Menu

NEW YORK – Hologic reported on Sunday revenue growth of greater than 2 percent for its fiscal first quarter 2020.

For the three months ended Dec. 28, 2019, the Marlborough, Massachusetts-based company recorded revenues of $850.5 million compared to $830.7 million in fiscal Q1 2019, and above the consensus Wall Street estimate of $839.2 million.

Hologic had guided to a range of $836 million to $850 million for fiscal Q1 2020.

On a constant currency basis, revenues for the recently completed quarter were up nearly 3 percent, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.